GTHX – g1 therapeutics, inc. (US:NASDAQ)
Stock Stats
News
6/25
08:04 am
gthx
Low
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its price target lowered by analysts at Needham & Company LLC from $12.00 to $6.00. They now have a "buy" rating on the stock.
6/25
08:04 am
gthx
Low
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its price target lowered by analysts at HC Wainwright from $9.00 to $3.00. They now have a "buy" rating on the stock.
6/25
06:25 am
gthx
Medium
G1 Therapeutics discontinue COSELA in TNBC following Phase III flop [Yahoo! Finance]
6/24
11:09 pm
gthx
Low
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $3.00 price target on the stock, down previously from $5.00.
6/24
10:15 am
gthx
High
G1 Therapeutics: Failure Of Breast Cancer Underscores Long-Term Uncertainty [Seeking Alpha]
5/1/2024
06:30 am
gthx
2.7%
MISS
2/28/2024
06:30 am
gthx
38.8%
BEAT
11/1/2023
06:30 am
gthx
-18.8%
MISS
8/2/2023
06:30 am
gthx
-4.9%
BEAT
6/25
06:08 am
Maintains
Buy
Buy
Needham
Medium
5.3%
6/25
06:08 am
Maintains
Buy
Buy
Needham
Medium
5.3%
6/24
11:09 pm
Reiterates
Outperform
Wedbush
Low
-0.5%
6/24
11:09 pm
Reiterates
Outperform
Wedbush
Low
-0.5%
6/13
08:07 am
Reiterates
Buy
Buy
Needham & Company LLC
Low
1.0%
6/24
06:35 am
gthx
Medium
Form 8-K G1 Therapeutics, Inc. For: Jun 24
6/14
04:44 pm
gthx
Medium
Form 4 G1 Therapeutics, Inc. For: Jun 13 Filed by: Sharpless Norman
6/14
04:42 pm
gthx
Medium
Form 4 G1 Therapeutics, Inc. For: Jun 13 Filed by: MUIR GLENN P
6/14
04:42 pm
gthx
Medium
Form 4 G1 Therapeutics, Inc. For: Jun 13 Filed by: Secor Alicia
6/14
04:40 pm
gthx
Medium
Form 4 G1 Therapeutics, Inc. For: Jun 13 Filed by: Flowers Cynthia Louise
Show more
Top News Gainers
8/7 Form 8-K G1 Therapeutics, Inc. For: Aug 07 35.3%
6/18 G1 Therapeutics Announces Updated Results from Phase 2 Trial of Trilaciclib in Combination with Chemotherapy Showed Statistically Significant Improvement in Overall Survival in Women with Metastatic Triple-Negative Breast Cancer 24.1%
5/9 Q1/2019 3/31/2019 EPS -0.640 ZacksConsensus -0.690 ActVsEst 0.050 - Beat 20.9%
9/10 G1 Therapeutics to Present New Clinical Data Across Pipeline at European Society for Medical Oncology (ESMO) 2019 Congress 11.0%
12/17 G1 Therapeutics Inc (NASDAQ: GTHX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 9.6%
4/8 G1 Therapeutics Inc (NASDAQ: GTHX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $13.00 price target on the stock. 7.5%
6/18 G1 Therapeutics Inc (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Cowen Inc. 7.2%
4/29 G1 Therapeutics to Provide First Quarter 2020 Corporate and Financial Update on May 6, 2020 6.4%
6/14 Form 4 G1 Therapeutics, Inc. For: Jun 12 Filed by: RUDNICK SETH 6.3%
4/24 Form DEF 14A G1 Therapeutics, Inc. For: Jun 11 6.2%
Top News Decliners
9/29 G1 Therapeutics Presents First Clinical Data on Oral SERD G1T48 Demonstrating Safety and Tolerability in Patients with Advanced Breast Cancer at ESMO 2019 -32.9%
3/13 Form 3 G1 Therapeutics, Inc. For: Mar 12 Filed by: Bailey John E. (Jack) Jr. -27.2%
3/12 G1 Therapeutics Announces Appointment of New Board Member and Chief Commercial Officer -17.2%
3/18 G1 Therapeutics Inc (NASDAQ: GTHX) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -16.9%
5/7 G1 Therapeutics Inc (NASDAQ: GTHX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.5%
5/10 Form 4 G1 Therapeutics, Inc. For: May 08 Filed by: Moses Jennifer K. -8.2%
7/30 Form 3 G1 Therapeutics, Inc. For: Jul 29 Filed by: Avagliano Mark -7.3%
12/27 G1 Therapeutics Inc (NASDAQ: GTHX) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -7.2%
4/3 G1 Therapeutics Inc (NASDAQ: GTHX) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -6.9%
4/7 G1 Therapeutics to Present at 19th Annual Needham Virtual Healthcare Conference on April 14, 2020 -6.1%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3